Bumper Offer - Urjas oil Just @ Rs. 1
Sporidex 500 Capsule (10), a prescription drug, is manufactured in various forms such as Capsule. Primarily, it is used for the treatment of Bacterial Infections. Sporidex 500 Capsule (10) also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Sporidex 500 Capsule (10). Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Sporidex 500 Capsule (10) include Nausea or vomiting, Allergic reaction, Rash. While these are the most often observed Sporidex 500 Capsule (10) side effects, there are can be others also. These have been listed below. Normally, these side effects of Sporidex 500 Capsule (10) are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
In addition, Sporidex 500 Capsule (10)'s effect is Safe during pregnancy and Safe for lactating mothers. Warnings related to Sporidex 500 Capsule (10)'s effects on the liver, heart and kidney, if any, have been listed below.
The section on Sporidex 500 Capsule (10) contraindications lists all such conditions.
Additionally, Sporidex 500 Capsule (10) may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Sporidex 500 Capsule (10) is considered safe while driving, and is addictive.
Sporidex 500 Capsule (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Sporidex 500 Capsule (10) is used -
Severe
Moderate
Mild
Common
Is the use of Sporidex 500 Capsule (10) safe for pregnant women?
There are no side effects of Sporidex in pregnant women.
Is the use of Sporidex 500 Capsule (10) safe during breastfeeding?
Sporidex does not show any side effects in breastfeeding women.
What is the effect of Sporidex 500 Capsule (10) on the Kidneys?
Sporidex may have mild side effects on the kidneys.
What is the effect of Sporidex 500 Capsule (10) on the Liver?
Using Sporidex does not have any harmful effects on the liver.
What is the effect of Sporidex 500 Capsule (10) on the Heart?
You can take Sporidex without any fear of damage to the heart.
Sporidex 500 Capsule (10) should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Sporidex 500 Capsule (10) unless your doctor advises you to do so -
Is this Sporidex 500 Capsule (10) habit forming or addictive?
Forming a habit of Sporidex 500 Capsule (10) has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Sporidex 500 Capsule (10) will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Sporidex 500 Capsule (10) should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Sporidex 500 Capsule (10) for mental disorders.
Interaction between Food and Sporidex 500 Capsule (10)
Taking Sporidex 500 Capsule (10) with food does not cause any problems.
Interaction between Alcohol and Sporidex 500 Capsule (10)
It is difficult to say anything about the effect of Sporidex 500 Capsule (10) and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Keflex® (cephalexin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 726
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 299-300
